MedTrace Logo

Tobacco Use in Opioid Agonist Treated Pregnant Women

NCT00497068 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2013-03-05

No results posted yet for this study

Summary

The primary objective of the proposed study is to evaluate the efficacy of tobacco abstinence-contingent voucher incentives versus non-tobacco abstinence-contingent incentives for reducing or eliminating tobacco use during pregnancy in methadone treated women. In addition, the impact that this intervention has in reducing the incidence and severity of methadone associated neonatal abstinence syndrome will also be examined.

Conditions

  • Nicotine Dependence

Interventions

BEHAVIORAL

tobacco abstinent contingent

Participants receive vouchers wiht monetary rewards for providing breath samples that show tobacco smoking abstinence

BEHAVIORAL

non-contingent

Participants receive vouchers regardless of tobacco use status

BEHAVIORAL

control

this group receives no vouchers

Sponsors & Collaborators

Principal Investigators

  • Hendree E Jones, PhD · Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2009-09-30
Completion
2010-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00497068 on ClinicalTrials.gov